Phase IB/II Study of Bazedoxifene in Combination with Palbociclib in Patients with Endocrine Resistant Hormone Receptor-Positive Breast Cancer

Request Access

Clinical Efficacy and Whole Exome Sequencing of Liquid Biopsies in a Phase IB/II study of Bazedoxifene and Palbociclib in Hormone Receptor-Positive Breast Cancer.

J. Tsuji, Tianyu Li, A. Grinshpun, et al.. (2022). Clinical cancer research : an official journal of the American Association for Cancer Research. Cited 8 times. https://doi.org/10.1158/1078-0432.CCR-22-2305
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747